Update on the role of antipsychotics in the treatment of Tourette syndrome
Daniel Huys, Katja Hardenacke, Pia Poppe, Christina Bartsch, Burak Baskin, Jens KuhnDepartment of Psychiatry and Psychotherapy, University of Cologne, Cologne, GermanyHead: Prof. Dr. Joachim KlosterkötterAbstract: Tourette syndrome (TS) is a neuropsychiatric disorder with typical onset...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/856b97fb9f904523b5cddfa2f702ed5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:856b97fb9f904523b5cddfa2f702ed5a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:856b97fb9f904523b5cddfa2f702ed5a2021-12-02T06:34:40ZUpdate on the role of antipsychotics in the treatment of Tourette syndrome1176-63281178-2021https://doaj.org/article/856b97fb9f904523b5cddfa2f702ed5a2012-03-01T00:00:00Zhttp://www.dovepress.com/update-on-the-role-of-antipsychotics-in-the-treatment-of-tourette-synd-a9453https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Daniel Huys, Katja Hardenacke, Pia Poppe, Christina Bartsch, Burak Baskin, Jens KuhnDepartment of Psychiatry and Psychotherapy, University of Cologne, Cologne, GermanyHead: Prof. Dr. Joachim KlosterkötterAbstract: Tourette syndrome (TS) is a neuropsychiatric disorder with typical onset in childhood and characterized by chronic occurrence of motor and vocal tics. The disorder can lead to serious impairments of both quality of life and psychosocial functioning, particularly for those individuals displaying complex tics. In such patients, drug treatment is recommended. The pathophysiology of TS is thought to involve a dysfunction of basal ganglia-related circuits and hyperactive dopaminergic innervations. Congruently, dopamine receptor antagonism of neuroleptics appears to be the most efficacious approach for pharmacological intervention. To assess the efficacy of the different neuroleptics available, a systematic, keyword-related search in PubMed (National Library of Medicine, Washington, DC) was undertaken. Much information on the use of antipsychotics in the treatment of TS is based on older data. Our objective was to give an update and therefore we focused on papers published in the last decade (between 2001 and 2011). Accordingly, the present review aims to summarize the current and evidence-based knowledge on the risk-benefit ratio of both first and second generation neuroleptics in TS.Keywords: Tourette, Tourette syndrome, neuroleptics, antipsychoticsHuys DHardenacke KPoppe PBartsch CBaskin BKuhn JDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2012, Iss default, Pp 95-104 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Huys D Hardenacke K Poppe P Bartsch C Baskin B Kuhn J Update on the role of antipsychotics in the treatment of Tourette syndrome |
description |
Daniel Huys, Katja Hardenacke, Pia Poppe, Christina Bartsch, Burak Baskin, Jens KuhnDepartment of Psychiatry and Psychotherapy, University of Cologne, Cologne, GermanyHead: Prof. Dr. Joachim KlosterkötterAbstract: Tourette syndrome (TS) is a neuropsychiatric disorder with typical onset in childhood and characterized by chronic occurrence of motor and vocal tics. The disorder can lead to serious impairments of both quality of life and psychosocial functioning, particularly for those individuals displaying complex tics. In such patients, drug treatment is recommended. The pathophysiology of TS is thought to involve a dysfunction of basal ganglia-related circuits and hyperactive dopaminergic innervations. Congruently, dopamine receptor antagonism of neuroleptics appears to be the most efficacious approach for pharmacological intervention. To assess the efficacy of the different neuroleptics available, a systematic, keyword-related search in PubMed (National Library of Medicine, Washington, DC) was undertaken. Much information on the use of antipsychotics in the treatment of TS is based on older data. Our objective was to give an update and therefore we focused on papers published in the last decade (between 2001 and 2011). Accordingly, the present review aims to summarize the current and evidence-based knowledge on the risk-benefit ratio of both first and second generation neuroleptics in TS.Keywords: Tourette, Tourette syndrome, neuroleptics, antipsychotics |
format |
article |
author |
Huys D Hardenacke K Poppe P Bartsch C Baskin B Kuhn J |
author_facet |
Huys D Hardenacke K Poppe P Bartsch C Baskin B Kuhn J |
author_sort |
Huys D |
title |
Update on the role of antipsychotics in the treatment of Tourette syndrome |
title_short |
Update on the role of antipsychotics in the treatment of Tourette syndrome |
title_full |
Update on the role of antipsychotics in the treatment of Tourette syndrome |
title_fullStr |
Update on the role of antipsychotics in the treatment of Tourette syndrome |
title_full_unstemmed |
Update on the role of antipsychotics in the treatment of Tourette syndrome |
title_sort |
update on the role of antipsychotics in the treatment of tourette syndrome |
publisher |
Dove Medical Press |
publishDate |
2012 |
url |
https://doaj.org/article/856b97fb9f904523b5cddfa2f702ed5a |
work_keys_str_mv |
AT huysd updateontheroleofantipsychoticsinthetreatmentoftourettesyndrome AT hardenackek updateontheroleofantipsychoticsinthetreatmentoftourettesyndrome AT poppep updateontheroleofantipsychoticsinthetreatmentoftourettesyndrome AT bartschc updateontheroleofantipsychoticsinthetreatmentoftourettesyndrome AT baskinb updateontheroleofantipsychoticsinthetreatmentoftourettesyndrome AT kuhnj updateontheroleofantipsychoticsinthetreatmentoftourettesyndrome |
_version_ |
1718399821879967744 |